Skip to main content
Thursday
May 01, 2025
Sign In
Subscribe
Epaper
Economy
Aviation
Banking
Bazaar
Budget
Industry
NBR
RMG
Corporates
Stocks
Analysis
Videos
TBS Today
TBS Stories
TBS World
News of the day
TBS Programs
Podcast
Editor's Pick
World+Biz
Features
Panorama
The Big Picture
Pursuit
Habitat
Thoughts
Splash
Mode
Tech
Explorer
Brands
In Focus
Book Review
Earth
Food
Luxury
Wheels
Subscribe
Epaper
GOVT. Ad
More
Sports
TBS Graduates
Bangladesh
Supplement
Infograph
Archive
Gallery
Long Read
Interviews
Offbeat
Magazine
Climate Change
Health
Cartoons
বাংলা
THURSDAY,
MAY 01, 2025
J&J
World+Biz
J&J and Merck Ebola vaccines produce lasting antibodies in children and adults -studies
Coronavirus chronicle
No Omicron deaths in J&J vaccine study in South Africa, scientist says
Global Economy
Healthcare giant Johnson & Johnson to split into two companies
Coronavirus chronicle
US brokers J&J-COVAX deal to send vaccines to conflict zones -Blinken
USA
J&J settles most Risperdal lawsuits, with $800 million in expenses
Coronavirus chronicle
US FDA clears Moderna, J&J Covid-19 boosters, backs use of different vaccine for boost
Coronavirus chronicle
Moderna or Pfizer booster works better for people vaccinated with J&J: study
USA
Six US states do not join $26 billion opioid settlements with distributors, J&J
Coronavirus chronicle
J&J says US FDA agrees to extend shelf life of its Covid-19 vaccine
World+Biz
J&J exploring putting talc liabilities into bankruptcy
World+Biz
J&J reaches $230 mln opioid settlement with New York state
Panorama
The real vaccine crisis isn’t about J&J or AstraZeneca
Coronavirus chronicle
J&J to deliver Covid vaccine to Europe from April 19
Show More